Featured News
More News
What’s the deali-O with new weight loss drugs? Part 1 (including Dr. Sun Kim)
I confess it took me a while to catch up with the buzz about Ozempic. The diabetes drug has been on everyone's lips -- or, more accurately for an injectable drug, getting under everyone's skin -- even before Jimmy Kimmel addressed the (suddenly svelte) elephant in the room at the Academy Awards when he quipped, "When I look around the room, I can't help but wonder...is Ozempic right for me?"
Mediterranean diet’s cellular effects revealed
Fat from olive oil and nuts boosts the numbers of two key cellular structures and protects membranes from damage, lengthening the lives of laboratory worms, Stanford Medicine-led study finds
Dr. Ananta Addala: Tech Increases Equity in Diabetes Care for Kids
According to a new study, providing continuous glucose monitoring with AI-enabled remote support yields better outcomes for youth across the socioeconomic spectrum.
Screen time: The good, the healthy and the mind-numbing (study by Dr. Thomas Robinson)
Thomas Robinson, MD, professor of pediatrics and of medicine, has been studying the effect of watching mobile and video screens since the early 1990s. But before your thoughts go to Tamagachis and Gameboys, Robinson took an interest in screens for their potential to support (and undermine) one's health.
Collaborative study including Sohail Husain, MD: Dietary Vitamin A Can Reduce the Risk for Chemotherapy-Induced Pancreatitis
Providers may be able to prevent chemotherapy-induced pancreatitis in pediatric patients by coprescribing vitamin A, according to new research presented at the 2022 annual meeting of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.